The role of surgical shunts in the treatment of pediatric portal hypertension
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Jul 2019 · 1 min read
In brief
In brief
Retrospective analysis of 34 pediatric portal hypertension patients treated with surgical shunts demonstrates favorable outcomes with 71% one-year patency and low complication rates. Meso-Rex bypass was the most common procedure, with 29% experiencing shunt complications requiring intervention. Study supports surgical shunts as effective treatment for medically refractory pediatric portal hypertension.
Written by the GCMD Library team from the article.
Statements in this article
Portal diversion by surgical shunt plays a major role in the treatment of medically refractory portal hypertension.
In this cohort, 85% of patients had prehepatic portal hypertension and 15% had intrahepatic portal hypertension.
The primary manifestations of portal hypertension were esophageal varices in 97% of patients and gastrointestinal bleeding in 77%.
Meso-Rex bypass was performed in 53% of patients, splenorenal shunt in 29%, and mesocaval shunt in 18%.
Wound complications occurred in 9% of patients, rebleeding events in 12%, and mortality in 3%.
Shunt complications including occlusion or stenosis occurred in 29% of patients postoperatively.
Four shunt complications occurred in the early postoperative period and required urgent intervention.
The 1-year primary patency rate was 71% and the 5-year primary patency rate was 66%.
Surgical shunts are a feasible and effective treatment option for pediatric portal hypertension.